5-hydroxy-3-oxo-3,4-dihydropyrazine-2-carboxamide

Catalog No. :
ACXGFQ522
CAS No. :
259793-98-1
Molecular Formula :
C5H5N3O3
Molecular Weight :
155.03

IUPAC Name:5-hydroxy-3-oxo-3,4-dihydropyrazine-2-carboxamide

5-hydroxy-3-oxo-3,4-dihydropyrazine-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$98.00Login to see priceIn stockInquiry
5g97%$327.00Login to see priceIn stockInquiry
25g97%$1308.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-hydroxy-3-oxo-3,4-dihydropyrazine-2-carboxamide
IUPAC Name5-hydroxy-3-oxo-3,4-dihydropyrazine-2-carboxamide
Molecular FormulaC5H5N3O3
Molecular Weight155.03
SMILESO=C(C1=NC=C(NC1=O)O)N
InChI KeyADAFSVZZOBXXAH-UHFFFAOYSA-N
SynonymPyrazinecarboxamide, 3,4-dihydro-5-hydroxy-3-oxo- (9CI);3,4-dihydro-5-hydroxy-3-oxo-2-Pyrazinecarboxamide;2-Pyrazinecarboxamide, 3,4-dihydro-5-hydroxy-3-oxo-;3-Hydroxy-5-oxo-4,5-dihydropyrazine-2-carboxamide
CAS No.259793-98-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXGFQ522 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACXGFQ522 route product structure diagram
    ACXGFQ522259793-98-1 In Stock
Inquiry

2. ACXGFQ522 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACXGFQ522 route product structure diagram
    ACXGFQ522259793-98-1 In Stock
Inquiry

Comments (0)